The dataset provides insights into the sold production of antisera and vaccines in Denmark, expressed in Million Euros. By 2023, the production value stood at 17.367 million Euros. Analyzing the year-on-year variations reveals considerable fluctuations, with noteworthy increases in 2014 and 2016, and significant declines in 2015 and 2017. The forecast from 2024 indicates a gradual increase with a steady positive growth rate.
Key trends:
- From 2013 to 2023, the market experienced high volatility, marked by substantial spikes and drops in production value.
- Year-on-year variation highlights drastic changes, such as an 85.63% drop in 2021 and an 83.86% increase in 2020.
- The Compound Annual Growth Rate (CAGR) over the last five years (2019-2023) shows an overall negative trend at -28.4%.
Future Trends to Watch For:
Forecasts for the period 2024 to 2028 suggest a more stable growth trajectory with a 5-year CAGR of 7.04%. The market expects a gradual increase in the production value, underpinned by continuous advancements in biopharmaceutical manufacturing and increasing global demand for vaccines. Monitoring changes in legal regulations, technological advances, and global health priorities will be crucial in understanding and predicting future market trajectories.
